The nation of Zimbabwe has declined a substantial US healthcare agreement valued at $367m (£272m) over five years because of the United States' request for confidential data.
This move came to light after a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa felt the agreement was "unbalanced".
An official representative has since stated that the United States was requesting health data for scientific study and commercial purposes while was unwilling to share the benefits from future vaccines.
"We must now begin the challenging and unfortunate process of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for further talks to reach a deal suitable to both sides so the country's critical HIV treatment initiative can be sustained.
Broader Context
This development comes after a similar case in neighbouring Kenya, where a high court suspended a related deal with the US following legal challenges were filed about the security of citizens' health data.
Since returning to office recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump argued its spending was "inefficient" and his administration was seeking direct bilateral deals to boost transparency and responsibility.
As per reports, 16 nations in Africa have to date signed similar agreements, representing over $18.3bn of fresh investment.
Specifics of the Declined Deal
The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation could have provided significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, without any corresponding guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.
"In essence, our country would supply the basic resources for medical research with no assurance that the resulting innovations would be accessible to our people if a new disease outbreak emerge."
National Interest and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending systems previously established via the international organization.
The spokesperson cited its Pandemic Benefit-Sharing framework created to deal with potential global health emergencies.
"This framework is designed to ensure that when a country provides its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the funds to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how future collaboration might be arranged in a way that respects the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but suggested that talks must proceed since much of the nation's HIV programmes were funded by foreign aid.
"In cases where technical issues arise, such as those relating to data governance or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," it commented.
This impasse emphasises the ongoing challenges between accepting much-needed international aid and protecting a country's data in an ever more data-driven world.